Search clinical trials for: Lansoprazole

Total 451 results

Takeda

Completed

Takepron Intravenous 30 mg Specified Drug-use Survey [Acute Stress Ulcer and Acute Gastric Mucosal Lesions]

Acute Stress Ulcer and Acute Gastric Mucosal Lesions
Takeda

Completed

Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux Disease

Gastroesophageal Reflux Disease

United States
Takeda

Completed

Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)

Gastric Ulcers | Duodenal Ulcers

Japan
Takeda

Completed

A Study to Evaluate the Pharmacokinetics of Dexlansoprazole 30 Milligram (mg) and 60 mg Delayed-release Capsules in Healthy Chinese Participants

Healthy Volunteers

China
Takeda

Completed

Lansoprazole Intravenous 30 mg Specified Drug-use Survey [Hemostatic Effect/Rebleeding Rate]

Gastric Ulcer, Duodenal Ulcer, Acute Stress Gastritis, and Acute Gastric Mucosal Lesions
Takeda

Completed

Safety and Efficacy of Lansoprazole in Patients With Reflux Disease

Gastroesophageal Reflux
Takeda

Completed

Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis

Esophagitis, Peptic | Esophagitis, Reflux

United States
Washington University School of Medicine

Active, not recruiting

Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy

Pancreatic Cancer | Pancreatitis | Pancreas Cancer | Duodenal Cancer | Ampullary Cancer | Pancreas Neuroendocrine Tumor | Distal Extrahepatic Cholangiocarcinoma

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage

Peptic Ulcer Hemorrhage

United States
Kaohsiung Veterans General Hospital.

Completed

Concomitant, Sequential, and Standard Triple Therapy for H. Pylori Infection

Helicobacter Pylori Infection

Taiwan
University of Medicine and Dentistry of New Jersey
National Institutes of Health (NIH)

Terminated

Esophageal Metaplasia Using a Novel Antibody: Reversibility by Proton Pump Inhibitor

Esophageal Metaplasia

United States
Kaohsiung Medical University Chung-Ho Memorial...

Completed

Comparing Clinical Efficacy of One-Week Dual Delayed-Release Dexlansoprazole and Esomeprazole for GERD Grade A and B

Gastroesophageal Reflux Disease
Dr. Waheed Rehman

Unknown

Impact of Pantoprazole on 24-H Glycemic Control and on Post-prandial Glucose Excursion in Patients With Type 2 Diabetes

Diabetes Mellitus
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fed Study

Healthy

India
Takeda

Completed

Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506)

Gastroesophageal Reflux | GERD | GORD

United Kingdom
Takeda

Completed

Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) or enGERD (Endoscopic-negative GERD) After Treatment With Pantoprazole (BY1023/M3-343)

GERD

Hungary, Austria, Germany, Australia
Takeda

Terminated

The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms (BY1023/NL511)

Gastroesophageal Reflux Disease | Non-erosive Reflux Disease

Switzerland, Netherlands
Ruttonjee Hospital

Completed

Famotidine Compared With Pantoprazole to Prevent Recurrent Aspirin-Induced Peptic Ulcer/Erosion

Peptic Ulcer/Erosions

China
Takeda

Completed

Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs

Duodenal Ulcer | Stomach Ulcer

Japan
Advanced Center for Specialty Care
Takeda

Unknown

Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy

Laryngopharyngeal Reflux | Hypertrophy of Lingual Tonsil

United States
Takeda

Completed

Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn

Gastroesophageal Reflux Disease

United States
National Institute of Diabetes and Digestive and...

Completed

The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid

Gastrinoma | Zollinger Ellison Syndrome

United States
Samsung Medical Center

Unknown

Trial of Proton Pump Inhibitor With Prokinetics or Placebo in Patients With Laryngopharyngeal Reflux Disease

Laryngopharyngeal Reflux Disease

Korea, Republic of
McMaster University
The Physicians' Services Incorporated Foundation

Completed

Re-Evaluating the Inhibition of Stress Erosions: Gastrointestinal Bleeding Prophylaxis In ICU (REVISE)

Stress Ulcer Prophylaxis

Canada, Australia, Saudi Arabia
University Health Network, Toronto
Princess Margaret Hospital, Canada

Completed

Pantoprazole With Doxorubicin for Advanced Cancer Patients With Extension Cohort of Patients With Solid Tumours

Advanced Solid Tumours

Canada
Asan Medical Center
Inje University; Pacific Pharmaceuticals

Completed

Comparison of 7-day and 14-day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori Eradication

Helicobacter Infection

Korea, Republic of
Far Eastern Memorial Hospital

Terminated

Comparison of Intravenous Pantoprazole and Famotidine for Stress Ulcer Prophylaxis

Stomach Ulcer

Taiwan
Takeda

Completed

Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)

Gastric Ulcers | Duodenal Ulcers

Japan
Takeda

Completed

A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn

Gastroesophageal Reflux

United States
Eli Lilly and Company

Completed

A Study of LY2940680 in Healthy Participants

Healthy Participants

United States
Kaohsiung Veterans General Hospital.

Unknown

Comparing the Efficacy of 10-day Reverse Hybrid Therapy and 10-day Triple Therapy Plus Bismuth Therapy.

Helicobacter Pylori Infection

Taiwan
Takeda

Completed

Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-339)

Gastroesophageal Reflux

Hungary, Austria, Germany, Poland
Takeda

Completed

Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients (BY1023/M3-341)

Gastroesophageal Reflux Disease (GERD)

United Kingdom, Australia, Belgium, Spain, Austria, Germany, Argentina, Brazil, Canada, France, Hong Kong, India, Italy, Korea, Republic of, Malaysia, Mexico, Poland, Portugal, Singapore, South Africa, Switzerland, Taiwan
Takeda

Completed

Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708)

Gastroesophageal Reflux Disease (GERD) | Peptic Ulcers

Germany
Takeda

Completed

Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis

Esophagitis, Peptic | Esophagitis, Reflux

United States, Poland, Bulgaria, India, Canada, Peru, Russian Federation, Australia, New Zealand, Czech Republic, Slovakia, South Africa, Latvia, Lithuania, Colombia, Germany
Takeda

Completed

Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat Heartburn

Gastroesophageal Reflux Disease

United States
Nycomed

Completed

Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Non-erosive Reflux or Gastroesophageal Reflux Disease (BY1023/DE-004)

Gastroesophageal Reflux

Germany
University of Cincinnati
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study of Pantoprazole for Sleepiness Associated With Acid Reflux and Sleep Apnea

Obstructive Sleep Apnea | Acid Reflux Disease

United States
Zahra Vahdat Shariatpanahi

Completed

Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection

Helicobacter Infection

Iran, Islamic Republic of
Takeda

Completed

A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin

Osteoarthritis | Peptic Ulcer
Children's Mercy Hospital Kansas City

Completed

Pharmacokinetics of Pantoprazole and CYP2C19 Activity in Children and Adolescents With GERD: A Pilot Study

Obesity | GERD

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage

Peptic Ulcer Hemorrhage
Nycomed

Completed

Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS) (PULS)

Erosive Gastroesophageal Reflux Disease | Non-Erosive Reflux Disease

Germany
Sahlgrenska University Hospital, Sweden

Completed

Symptom Evaluation After Cessation of a Proton Pump Inhibitor in Healthy Volunteers

Healthy

Sweden
Phillip Brian Smith
The Emmes Company, LLC

Completed

PK Study With Pantoprazole in Obese Children and Adolescents (PAN01)

Gastroesophageal Reflux Disease

United States
University of Missouri-Columbia

Terminated

Optimal Dose of Proton Pump Inhibitors Following an Upper Gastrointestinal Bleed

Upper Gastrointestinal Bleed

United States
Johann Wolfgang Goethe University Hospital

Withdrawn

Influence of Pantoprazole on Human Myocardial Contractility at Patients With Congestive Heart Failure

Congestive Heart Failure

Germany
Kaohsiung Veterans General Hospital.

Completed

Comparing the Efficacy of Reverse Hybrid Therapy and Bismuth Quadruple Therapy

Helicobacter Pylori Infection

Taiwan
Centre de Recherche de l'Institut Universitaire...

Completed

Evaluation of the Influence of Statins and Proton Pump Inhibitors on Clopidogrel Antiplatelet Effects (SPICE)

Coronary Artery Disease

Canada
Lotung Poh-Ai Hospital
Tomorrow Medical Foundation

Withdrawn

Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer Rebleeding

Peptic Ulcer

3

Subscribe